Rexulti Tablet
Pricing Report NDC 59148-039-13

Current NADAC: $49.50907 per EA · Effective Sep 23, 2026 · Est. package price $1,485.27 (30 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Rexulti (NDC 59148-039-13) is $49.50907 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Otsuka America Pharmaceutical, Inc., this medication is distributed in a 1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$49.50907
Per EA

Effective Date
Sep 23, 2026
Billable Units
30 EA
Estimated Package Price
$1,485.27
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2016, the NADAC wholesale price for (NDC ) has moved within a range of $29.87230 to $49.60415 per EA. Over this 10 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$29.8723 - $49.6042
Market Volatility
66.05% Variance
Latest Trend
0.04%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $49.50907 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $49.53032 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $49.56287 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $49.58085 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $49.58374 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $49.60415 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $49.60415 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $49.60415 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $48.32357 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $48.32721 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $48.32287 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $48.30527 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026